Global Information
회사소개 | 문의 | 비교리스트

창상관리용 생물제제 시장 : 세계 산업 동향, 점유율, 규모, 성장률, 기회, 예측(2021-2026년)

Wound Care Biologics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

리서치사 IMARC Services Private Limited
발행일 2021년 05월 상품코드 1007157
페이지 정보 영문 배송안내 2-3일 (영업일 기준)
가격
US $ 2,299 ₩ 3,265,000 PDF (Single User License)
US $ 3,399 ₩ 4,828,000 PDF (5 User License)
US $ 4,499 ₩ 6,391,000 PDF (Corporate License)


창상관리용 생물제제 시장 : 세계 산업 동향, 점유율, 규모, 성장률, 기회, 예측(2021-2026년) Wound Care Biologics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026
발행일 : 2021년 05월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 창상관리용 생물제제 시장 규모는 2015-2020년 강력한 성장을 보였습니다. 창상관리용 생물제제는 감염증의 제어 및 치유에 사용되는 천연자원으로부터 추출 또는 반합성된 약제를 가리킵니다. 창상 치유는 염증, 섬유 조직의 축적, 콜라겐의 침착, 상피 세포층의 형성 및 기타 파괴를 포함한 복잡한 프로세스입니다. 생물학적 창상 치유 치료는 활성 생물학적 요인에 의해 자연 수복 메커니즘을 회복하는 능력을 가지고 있습니다. 예를 들면 항균, 항염증 또는 항산화 특성을 가진 식물 유래 활성 생체분자는 창상 치유 프로세스의 진행에서 효과적인 것으로 증명되고 있습니다. 창상 치유 분야에서 시행된 최근의 기술 진보에는 대용 피부, 생체막, 스캐폴드, 유체 전도성 드레싱, 생물제제 등이 있습니다.

만성 피부 창상은 화상, 피부암, 감염증, 외상 또는 당뇨병 등의 기초 질환이 원인으로 발생할 가능성이 있습니다. 고령자 인구의 증가와 함께 이 질병의 만연이 증가하고 있으므로 창상 치유를 촉진하고, 신속한 회복을 촉진할 수 있는 치료법의 수요가 높아지고 있습니다. 이것과 함께 환자 사이에 창상관리용 생물제제의 이점에 관한 인식을 높이기 위해 전 세계의 정부에 의해 몇개의 구상이 시행되고 있습니다. 또한 제조업체는 이것을 보다 입수하기 쉽게 하기 위해 차세대 비용 효과가 높은 고품질 생물제제도 개발하고 있습니다. 또한 많은 리서치 센터 및 헬스케어 센터가 창상관리 치료를 현대화하고, 창상 치유용 혁신적인 약제를 개발하기 위한 파트너십을 체결하고 있습니다. 예를 들면 연구자는 항균 화합물을 창상 피복재 자체에 통합하는 것에 초점을 맞추고 있습니다. 이 재료는 하이드로겔 및 폼 등의 기존 창상 피복재와 베타인, 은, 키틴 또는 polyhexamethylene biguanide 등의 항균성 화합물을 조합하고 있습니다. 2021-2026년 세계의 창상관리용 생물제제 시장은 약 8%의 CAGR로 성장할 것으로 예측되고 있습니다.

창상관리용 생물제제 시장에 대해 조사했으며, 시장의 개요와 제품별, 창상 유형별, 용도별, 최종사용자별, 지역별 동향 및 시장에 참여하는 기업의 개요 등을 정리하여 전해드립니다.

목차

제1장 서문

제2장 범위와 조사 방법

제3장 개요

제4장 서론

제5장 세계의 창상관리용 생물제제 시장

  • 시장 개요
  • 시장 실적
  • COVID-19의 영향
  • 제품별 시장 세분화
  • 창상 유형별 시장 세분화
  • 용도별 시장 세분화
  • 최종사용자별 시장 세분화
  • 지역별 시장 세분화

제6장 시장 세분화, 제품별

  • 생물학적 피부 대체품
  • 외용제

제7장 시장 세분화, 창상 유형별

  • 궤양
  • 외과적 및 외상성 창상
  • 화상

제8장 시장 세분화, 용도별

  • 급성 창상
  • 만성 창상
  • 외과적 창상

제9장 시장 세분화, 최종사용자별

  • 병원
  • ASC
  • 화상 센터와 창상 클리닉

제10장 시장 세분화, 지역별

  • 아시아태평양
  • 유럽
  • 북미
  • 중동과 아프리카
  • 라틴아메리카

제11장 SWOT 분석

제12장 밸류체인 분석

제13장 Porter의 산업 분석

제14장 가격 분석

제15장 경쟁 구도

  • 시장 구조
  • 주요 기업
  • 주요 기업의 개요
    • Smith & Nephew
    • Molnlycke Health Care
    • Integra lifesciences
    • Osiris Therapeutics
    • Avita Medical
    • ConvaTec Group
    • Cytori Therapeutics
    • Mylan
    • Johnson & Johnson
    • Leap Therapeutics
    • Nuo Therapeutics
    • Mallinckrodt
    • Wright Medical
    • Mimedx Group
    • Solsys Medical
KSA 21.06.09

List of Figures

  • Figure 1: Global: Wound Care Biologics Market: Major Drivers and Challenges
  • Figure 2: Global: Wound Care Biologics Market: Sales Value (in Billion US$), 2015 - 2020
  • Figure 3: Global: Wound Care Biologics Market: Breakup by Product (in %), 2020
  • Figure 4: Global: Wound Care Biologics Market: Breakup by Wound Type (in %), 2020
  • Figure 5: Global: Wound Care Biologics Market: Breakup by Application (in %), 2020
  • Figure 6: Global: Wound Care Biologics Market: Breakup by End-User (in %), 2020
  • Figure 7: Global: Wound Care Biologics Market: Breakup by Region (in %), 2020
  • Figure 8: Global: Wound Care Biologics Market Forecast: Sales Value (in Billion US$), 2021-2026
  • Figure 9: Global: Wound Care Biologics Industry: SWOT Analysis
  • Figure 10: Global: Wound Care Biologics Industry: Value Chain Analysis
  • Figure 11: Global: Wound Care Biologics Industry: Porter's Five Forces Analysis
  • Figure 12: Global: Wound Care Biologics (Biologic Skin Substitutes) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 13: Global: Wound Care Biologics (Biologic Skin Substitutes) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 14: Global: Wound Care Biologics (Topical Agents) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 15: Global: Wound Care Biologics (Topical Agents) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 16: Global: Wound Care Biologics (Ulcers) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 17: Global: Wound Care Biologics (Ulcers) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 18: Global: Wound Care Biologics (Surgical and Traumatic Wounds) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 19: Global: Wound Care Biologics (Surgical and Traumatic Wounds) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 20: Global: Wound Care Biologics (Burns) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 21: Global: Wound Care Biologics (Burns) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 22: Global: Wound Care Biologics (Acute Wound) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 23: Global: Wound Care Biologics (Acute Wound) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 24: Global: Wound Care Biologics (Chronic Wound) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 25: Global: Wound Care Biologics (Chronic Wound) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 26: Global: Wound Care Biologics (Surgical Wound) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 27: Global: Wound Care Biologics (Surgical Wound) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 28: Global: Wound Care Biologics (Hospitals) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 29: Global: Wound Care Biologics (Hospitals) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 30: Global: Wound Care Biologics (ASCs) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 31: Global: Wound Care Biologics (ASCs) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 32: Global: Wound Care Biologics (Burn Centres and Wound Clinics) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 33: Global: Wound Care Biologics (Burn Centres and Wound Clinics) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 34: Asia Pacific: Wound Care Biologics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 35: Asia Pacific: Wound Care Biologics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 36: North America: Wound Care Biologics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 37: North America: Wound Care Biologics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 38: Europe: Wound Care Biologics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 39: Europe: Wound Care Biologics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 40: Middle East and Africa: Wound Care Biologics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 41: Middle East and Africa: Wound Care Biologics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 42: Latin America: Wound Care Biologics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 43: Latin America: Wound Care Biologics Market Forecast: Sales Value (in Million US$), 2021-2026

List of Tables

  • Table 1: Global: Wound Care Biologics Market: Key Industry Highlights, 2020 and 2026
  • Table 2: Global: Wound Care Biologics Market Forecast: Breakup by Product (in Million US$), 2021-2026
  • Table 3: Global: Wound Care Biologics Market Forecast: Breakup by Wound Type (in Million US$), 2021-2026
  • Table 4: Global: Wound Care Biologics Market Forecast: Breakup by Application (in Million US$), 2021-2026
  • Table 5: Global: Wound Care Biologics Market Forecast: Breakup by End-User (in Million US$), 2021-2026
  • Table 6: Global: Wound Care Biologics Market Forecast: Breakup by Region (in Million US$), 2021-2026
  • Table 7: Global: Wound Care Biologics Market Structure
  • Table 8: Global: Wound Care Biologics Market: Key Players

The global wound care biologics market exhibited strong growth during 2015-2020. Wound care biologics refer to drugs extracted or semi-synthesized from natural sources which are used for controlling and healing infections. Wound healing is a complex process involving inflammation, accumulation of fibrous tissue, deposition of collagen, formation of epithelial cell layers and other disruptions. Biologic wound healing treatments possess the ability to restore the natural repair mechanism through active biological agents. For instance, plant-derived active biomolecules with antimicrobial, anti-inflammatory or antioxidant properties have proven efficacious in advancing the wound-healing process. Some of the recent technological advancements made in the field of wound healing include skin substitutes, bio-membranes, scaffolds, hydroconductive dressings and biologics.

Chronic skin wounds can be caused due to burns, skin cancers, infections, trauma or an underlying medical condition such as diabetes. With the growing prevalence of these ailments along with the expanding geriatric population, there has been a rise in the demand for treatments that can accelerate wound healing and facilitate a speedy recovery. Along with this, several initiatives have been undertaken by governments across the globe to create awareness about the benefits of wound care biologics among patients. Apart from this, manufacturers are also developing next-generation, cost-effective and high-quality biologics to make them more accessible. Moreover, many research and healthcare centers are entering into partnerships to modernize wound care treatments and develop innovative drugs for healing wounds. For example, researchers are focusing on integrating antimicrobial compounds into the wound dressing itself. These materials combine traditional wound dressings such as hydrogels or foams with antimicrobial compounds such as betaine, silver, chitin, or polyhexamethylene biguanide. Looking forward, IMARC Group expects the global wound care biologics market to grow at a CAGR of around 8% during 2021-2026.

Report Coverage:

  • Historical, Current and Future Market Trends

Market Breakup by Product:

  • Biologic Skin Substitutes
  • Human Donor Tissue-Derived Products
  • Acellular Animal -Derived Products
  • Biosynthetic Products
  • Topical Agents

Market Breakup by Wound Type:

  • Ulcers
  • Diabetic Foot Ulcers
  • Venous Ulcers
  • Pressure Ulcers
  • Others
  • Surgical and Traumatic Wounds
  • Burns

Market Breakup by Application:

  • Acute Wound
  • Chronic Wound
  • Surgical Wound

Market Breakup by End-User:

  • Hospitals
  • ASCs
  • Burn Centres and Wound Clinics

Market Breakup by Region:

  • Asia Pacific
  • Europe
  • North America
  • Middle East and Africa
  • Latin America

Competitive Landscape:

  • The report has also analysed the competitive landscape of the market with some of the key players being Smith & Nephew, Molnlycke Health Care, Integra lifesciences, Osiris Therapeutics, Avita Medical, ConvaTec Group, Cytori Therapeutics, Mylan, Johnson & Johnson, Leap Therapeutics, Nuo Therapeutics, Mallinckrodt, Wright Medical, Mimedx Group, Solsys Medical, etc.

Key Questions Answered in This Report:

  • How has the global wound care biologics market performed so far and how will it perform in the coming years?
  • What are the key regional markets in the global wound care biologics industry?
  • What has been the impact of COVID-19 on the global wound care biologics industry?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the wound type?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the global wound care biologics industry?
  • What are the key driving factors and challenges in the global wound care biologics industry?
  • What is the structure of the global wound care biologics industry and who are the key players?
  • What is the degree of competition in the global wound care biologics industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Wound Care Biologics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Product
  • 5.5 Market Breakup by Wound Type
  • 5.6 Market Breakup by Application
  • 5.7 Market Breakup by End-User
  • 5.8 Market Breakup by Region
  • 5.9 Market Forecast

6 Market Breakup by Product

  • 6.1 Biologic Skin Substitutes
    • 6.1.1 Market Trends
    • 6.1.2 Market Breakup by Type
      • 6.1.2.1 Human Donor Tissue-Derived Products
      • 6.1.2.2 Acellular Animal-Derived Products
      • 6.1.2.3 Biosynthetic Products
    • 6.1.3 Market Forecast
  • 6.2 Topical Agents
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Wound Type

  • 7.1 Ulcers
    • 7.1.1 Market Trends
    • 7.1.2 Market Breakup by Type
      • 7.1.2.1 Diabetic Foot Ulcers
      • 7.1.2.2 Venous Ulcers
      • 7.1.2.3 Pressure Ulcers
      • 7.1.2.4 Others
    • 7.1.3 Market Forecast
  • 7.2 Surgical and Traumatic Wounds
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Burns
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Acute Wound
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Chronic Wound
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Surgical Wound
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by End-User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 ASCs
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Burn Centres and Wound Clinics
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 Asia Pacific
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Europe
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 North America
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Middle East and Africa
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast
  • 10.5 Latin America
    • 10.5.1 Market Trends
    • 10.5.2 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porter's Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Smith & Nephew
    • 15.3.2 Molnlycke Health Care
    • 15.3.3 Integra lifesciences
    • 15.3.4 Osiris Therapeutics
    • 15.3.5 Avita Medical
    • 15.3.6 ConvaTec Group
    • 15.3.7 Cytori Therapeutics
    • 15.3.8 Mylan
    • 15.3.9 Johnson & Johnson
    • 15.3.10 Leap Therapeutics
    • 15.3.11 Nuo Therapeutics
    • 15.3.12 Mallinckrodt
    • 15.3.13 Wright Medical
    • 15.3.14 Mimedx Group
    • 15.3.15 Solsys Medical
Back to Top
전화 문의
F A Q